Cargando…

Expression of Membrane‐associated Lymphotoxin/Tumor Necrosis Factor‐β on Human Lymphokine‐activated Killer Cells

A membrane‐associated lymphotoxin (LT)‐related molecule was detected on human lymphokine‐activated killer (LAK) cells by flow cytometric analysis. Kinetic analysis revealed that the LT antigenicity on LAK cells appeared at 9 h after the beginning of culture and was maintained thereafter. By autoradi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abe, Yasuhito, Miyake, Masazumi, Horiuchi, Atsushi, Kimura, Shigeru, Yasuo, Yasuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1991
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918213/ https://www.ncbi.nlm.nih.gov/pubmed/1900262 http://dx.doi.org/10.1111/j.1349-7006.1991.tb01740.x

Ejemplares similares

Membrane‐associated Lymphotoxin Expression and Functional Analysis of Lymphokine‐activated Killer Cells Derived from Tumor‐infiltrating Lymphocytes
por: Horiuchi, Atsushi, et al.
Publicado: (1993)

Inhibition of Tumor Necrosis Factor‐α and β Secretion by Lymphokine Activated Killer Cells by Transforming Growth Factor‐β
por: Naganuma, Hirofumi, et al.
Publicado: (1994)

The Tumor Necrosis Factor Superfamily Members TNFSF14 (LIGHT), Lymphotoxin β and Lymphotoxin β Receptor Interact to Regulate Intestinal Inflammation
por: Giles, Daniel A., et al.
Publicado: (2018)

Generation and Characterization of Lymphokine‐activated Killer Cells against Fresh Human Leukemia Cells
por: Tahara, Tohru, et al.
Publicado: (1988)

Mature Follicular Dendritic Cell Networks Depend on Expression of Lymphotoxin β Receptor by Radioresistant Stromal Cells and of Lymphotoxin β and Tumor Necrosis Factor by B Cells
por: Endres, Robert, et al.
Publicado: (1999)

Augmentation by Tumor Necrosis Factor α of the Systemic Therapeutic Effect of Lymphokine‐activated Killer Cells in Adoptive Immunotherapy of Murine Tumor
por: Kato, Kazunori, et al.
Publicado: (1991)

Multiple roles for tumor necrosis factor-α and lymphotoxin α/β in immunity and autoimmunity
por: McDevitt, Hugh, et al.
Publicado: (2002)

Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.
por: Rajaram, N., et al.
Publicado: (1990)

Membrane lymphotoxin-α(2)β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist
por: Kucka, Kirstin, et al.
Publicado: (2021)

Lymphokine-activated killer cells. Analysis of progenitors and effectors
Publicado: (1986)

Characterization of Transendothelial Migratory Lymphokine‐activated Killer Cells
por: Nakano, Koji, et al.
Publicado: (1996)

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells
Publicado: (1983)

Establishment of Mouse Lymphokine‐activated Killer Cell Clones and Their Properties
por: Kato, Kazunori, et al.
Publicado: (1991)

Enhanced lymphokine-activated killer cell activity by an immunomodulator, Roquinimex.
por: Vaz, F., et al.
Publicado: (1995)

Induction of lymphokine-activated killer-like cells by cancer chemotherapy
Publicado: (1988)

The Heterogeneity of Target Recognition by Lymphokine‐activated Killer Precursor Cells
por: Ibayashi, Yukihiro, et al.
Publicado: (1990)

Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells
Publicado: (1988)

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis
Publicado: (1990)

Lymphotoxin α/β and Tumor Necrosis Factor Are Required for Stromal Cell Expression of Homing Chemokines in B and T Cell Areas of the Spleen
por: Ngo, Vu N., et al.
Publicado: (1999)

Transcriptome Analysis Identifies Accumulation of Natural Killer Cells with Enhanced Lymphotoxin-β Expression during Glioblastoma Progression
por: Monaco, Gianni, et al.
Publicado: (2022)

IMMUNOTHERAPY OF SOLID TOMOR BY INTRATUMORAL INFUSION OF LYMPHOKINE‐ACTIVATED KILLER CELLS
por: Yamaki, Toshiaki, et al.
Publicado: (1988)

Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes
Publicado: (1987)

Lymphokines
por: Hamblin, Anne S
Publicado: (1998)

Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells
Publicado: (1989)

Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases
Publicado: (1991)

Interleukin 5 enhances interleukin 2-mediated lymphokine-activated killer activity
Publicado: (1989)

Immune activation by combination human lymphokine-activated killer and dendritic cell therapy
por: West, E J, et al.
Publicado: (2011)

Enhancing Effect of Pokeweed Mitogen on the Proliferation and the Cytotoxicity of Lymphokine‐activated Killer Cells
por: Kimoto, Yasuhiko, et al.
Publicado: (1992)

Lymphokine‐activated Killer Induction and Its Regulation by Macrophages in Malignant Pleural Effusions
por: Yanagawa, Hiroaki, et al.
Publicado: (1989)

Tumor Necrosis Factor α and Lymphotoxin α Are Not Required for Induction of Acute Experimental Autoimmune Encephalomyelitis
por: Frei, Karl, et al.
Publicado: (1997)

Are different stoichiometries feasible for complexes between lymphotoxin-alpha and tumor necrosis factor receptor 1?
por: Mascarenhas, Nahren Manuel, et al.
Publicado: (2012)

Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor
por: Winter, Hauke, et al.
Publicado: (2007)

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis
Publicado: (1986)

Lymphokine-activated killer cell susceptibility and adhesion molecule expression of multidrug resistant breast carcinoma
por: Savas, Burhan, et al.
Publicado: (2006)

Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon
Publicado: (1986)

Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii
Publicado: (1992)

Influence of transfusion of lymphokine-activated T killer cells on inflammatory responses in dogs after laparotomy
por: MIE, Keiichiro, et al.
Publicado: (2016)

Two Populations of Mouse Lymphokine‐activated Killer Cells Separated by Use of Soybean Agglutinin
por: Takano, Mariko, et al.
Publicado: (1989)

Reinforced Cytotoxicity of Lymphokine‐activated Killer Cells toward Glioma Cells by Transfection of the Killer Cells with the γ‐Interferon Gene
por: Mizuno, Masaaki, et al.
Publicado: (1995)

Transfection‐induced Tumor Necrosis Factor‐α Increases the Susceptibility of Human Glioma Cells to Lysis by Lymphokine‐activated Killer Cells: Continuous Expression of Intercellular Adhesion Molecule‐1 on the Glioma Cells
por: Takaoka, Toru, et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_5ocd7hj3hr8vqv5lvmbji7854p